Interference 103,781
Mycogen Plant Sci., Inc. v. Monsanto Co., 61 F.Supp.2d 199
(D. Del. 1999), affirmed in Mycogen Plant Sci., Inc. v. Monsanto
Inc., 243 F.3d 1316, 58 USPQ2d 1030 (Fed. Cir. 2001), and denied
defendant’s motion for summary judgment that the contested claims
of Mycogen’s ‘831 patent are invalid for noncompliance with the
enablement requirement of the first paragraph of 35 U.S.C. § 112
as moot (Paper No. 127, Exh. A).
March 12, 2001 - On appeal from the decision of the U.S.
District Court for the District of Delaware in Mycogen Plant
Sci., Inc. v. Monsanto Co., 61 F.Supp.2d 199 (D. Del. 1999),
the U.S. Court of Appeals for the Federal Circuit:
. . . affirm[ed] the verdict of noninfringement based
on patent invalidity due to prior invention pursuant
to 35 U.S.C. § 102(g). This makes it unnecessary to
address the finding of lack of enablement pursuant to
35 U.S.C. § 112.
Mycogen Plant Sci., Inc. v. Monsanto Co., 243 F.3d at 1320,
58 USPQ2d at 1033 (Paper No. 146).
May 30, 2001 - On appeal from the decision of the U.S.
District Court for the Southern District of California in Mycogen
Plant Sci., Inc. v. Monsanto Co., No. 95-CV-653 (S.D. Cal.
Nov. 10, 1999)(Paper No. 127, Exh. A), the U.S. Court of Appeals
for the Federal Circuit affirmed-in-part, reversed-in-part, and
remanded. Mycogen Plant Sci., Inc. v. Monsanto Co., 252 F.3d
-165-
Page: Previous 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 Next
Last modified: November 3, 2007